Drug | Cream
Hydroquinone 2% w/w + Tretinoin 0.025% w/w + Mometasone furoate 0.1% w/w
Treatment of melasma (facial hyperpigmentation), dark spots, chloasma, post-inflammatory hyperpigmentation (as prescribed).
Hydroquinone reduces melanin formation by inhibiting tyrosinase, lightening dark patches. Tretinoin increases skin cell turnover and improves penetration of hydroquinone. Mometasone (a corticosteroid) reduces inflammation and irritation, but prolonged use can cause steroid-related skin damage.
For external use only. Apply a thin layer to affected areas once daily at night or as directed by a dermatologist; avoid eyes, lips and broken skin. Use sunscreen (SPF 30+) in daytime and limit sun exposure; do not apply more than prescribed or for longer duration.
Common side effects of Skinlite Cream may include:
Use only under medical supervision; steroid-containing triple-combination creams are not for long-term or unsupervised use. Avoid use on large areas, under occlusion, or on infected/ulcerated skin. Stop and consult doctor if severe irritation, swelling, or worsening pigmentation occurs; risk of rebound hyperpigmentation and steroid-induced side effects (skin atrophy, rosacea-like dermatitis). Not recommended for children; avoid using on face for prolonged periods. Use broad-spectrum sunscreen; tretinoin increases photosensitivity. Hydroquinone may rarely cause ochronosis with prolonged use.
